Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2017–2022 · research · R01
Role of the Histone Modifier KDM2A in Lung Cancer
Min Gyu Lee · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · research · R01
Cell Cycle Blockade and Therapeutic Sensitization
Zahid H Siddik · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2027 · research · R01
Signaling Mechanisms of Opioid-Induced Hyperalgesia and Tolerance
Shao-Rui Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Inhibition of brain metastasis by blocking MAPK12 driver kinase functions
Dihua Yu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2027 · research · R25
Scientific Communication Advances Research Excellence (SCOARE) 2.0
Carrie A. Cameron · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · research · R50
Functional Proteomics by Reverse Phase Protein Array in Cancer
Yiling Lu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · research · R01
53BP1-dependent pathway in DNA repair
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017 · career development · Young Investigator Award
Improving Prediction of Relapse in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Using Next-Generation Sequencing
Nicholas Short · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2017 · research · Pancreatic Cancer Action Network-AACR Career Development Award
The regulation of oncogene addiction by YAP pathway in pancreatic cancer
Haoqiang Ying · The University of Texas MD Anderson Cancer Center · funded by American Association for Cancer Research
2017 · research · SU2C Innovative Research Grant (Class of 2017)
DELINEATING THE ROLE OF THE MICROBIOME IN MODULATING TUMOR AND HOST IMMUNITY
Jennifer A. Wargo · The University of Texas MD Anderson Cancer Center · funded by Stand Up To Cancer
2017–2019 · research · Drug Discovery
Therapeutic Potential of Dual Leucine Zipper Kinase Inhibitors in Alzheimer's Disease
William Ray · The University of Texas MD Anderson Cancer Center · funded by Alzheimer's Drug Discovery Foundation
2017 · career development · Young Investigator Award
High throughput multiplexed immunological profiling of glioblastoma
Wen Jiang · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2017 · fellowship · AACR Anna D. Barker Fellowship in Basic Cancer Research
Elucidating the exosome “road map” in normal physiology and cancer
Amanda Haltom · The University of Texas MD Anderson Cancer Center · funded by American Association for Cancer Research
2017 · career development · Young Investigator Award
Targeting the EZH2-STAT3 Pathway in Renal Medullary Carcinoma
Pavlos Msaouel · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2017 · career development · Career Development Award
Phase I/II Study of Intratumoral CD40 Agonistic Monoclonal Antibody APX005M in Combination with Systemic Pembrolizumab in Patients with Metastatic Melanoma
Adi Diab · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2017 · career development · Career Development Award
Molecular, immune, and clinical significance of obesity in advanced melanoma
Jennifer Mcquade · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2017 · fellowship · AACR-John and Elizabeth Leonard Family Foundation Basic Cancer Research Fellowship
Tracking stromal interactions in TNBC chemoresistance by single cell RNAseq
Ruli Gao · The University of Texas MD Anderson Cancer Center · funded by American Association for Cancer Research
2017 · career development · Young Investigator Award
Investigation of in situ predictors of response to immune therapy in metastatic melanoma
Meredith Mckean · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2017 · career development · Young Investigator Award
Targeted Protein Degradation for Oncotherapy: EZH2 PROTACs for the Treatment of Lymphoma
James Link · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2017 · fellowship · QuadW Foundation-AACR Fellowship for Clinical/Translational Sarcoma Research
Overcoming primary resistance to VEGF/VEGFR targeted agents in angiosarcoma
Michael J. Wagner · The University of Texas MD Anderson Cancer Center · funded by American Association for Cancer Research
2017–2027 · research · R25
Scientific Communication Advances Research Excellence (SCOARE) 2.0
Carrie A. Cameron · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2028 · cooperative agreement · U24
MD Anderson Cancer Immune Monitoring and Analysis Center MDA-CIMAC
Gheath Al-Atrash · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2027 · research · R01
Molecular Determinants of Synaptic Plasticity in Chronic Pain
Shao-Rui Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · program · P40
RESOURCE CORE
Christian R Abee · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · program · P50
Project 1: High Grade Cancers: Capitalizing on PARPness in Ovarian Carcinoma
Gordon B. Mills · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
PDX Core
Bingliang Fang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · program · P50
Core 2: Bioinformatics and Biostatistics Core
Ying Yuan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · program · P50
Core 1: Pathology Core
Jinsong Liu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
Research Project 1: PDX-based trials of precision medicine for treatment of KRAS mutant lung cancers
Bingliang Fang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · program · P01
Project 2: Error-free and Mutagenic Processing of Crosslinks
Karen M Vasquez · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
PDX Core
Bingliang Fang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · program · P50
Developmental Research Program
Anil K Sood · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · program · P01
Core B: Molecular Substrates Core
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2028 · program · P40
Specific Pathogen Free 18 Baboon Research Resource {(SPF18BRR): Resource Core
William D Hopkins · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2022 · program · P40
APPLIED RESEARCH
Christian R Abee · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · program · P01
Project 4: Coordinating Nucleolytic Pathways During Crosslink Repair
Junjie Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
Administrative Core
Jack Roth · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
Project 2: Building Combinatorial Therapies against KRAS-mutant Colorectal and Pancreatic Cancer
Scott Kopetz · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
Pilot Projects and Trans-Network Activities
Jack Roth · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2017–2023 · program · P50
Project 3: The Role of Macrophages in Resistance to Anti-VEGF Drugs in Ovarian Cancer
Anil K Sood · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
